BOUT:NYE-Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF (USD)

ETF | Mid-Cap Growth |

Last Closing

USD 35.1701

Change

+0.09 (+0.26)%

Market Cap

USD 0.01B

Volume

230.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-06-02 )

Largest Industry Peers for Mid-Cap Growth

Symbol Name Price(Change) Market Cap
IWP iShares Russell Mid-Cap Growth..

-0.69 (-0.51%)

USD 18.06B
VOT Vanguard Mid-Cap Growth Index ..

-0.05 (-0.02%)

USD 15.90B
IJK iShares S&P Mid-Cap 400 Growth..

-0.05 (-0.06%)

USD 8.83B
XMMO Invesco S&P MidCap Momentum ET..

+0.21 (+0.17%)

USD 3.81B
IVOG Vanguard S&P Mid-Cap 400 Growt..

-0.26 (-0.23%)

USD 1.08B
CWS AdvisorShares Focused Equity E..

+0.02 (+0.02%)

USD 0.18B
ETHO Amplify ETF Trust

-0.07 (-0.12%)

USD 0.18B
BFOR Barron's 400 ETF

-0.10 (-0.14%)

USD 0.15B
IPO Renaissance IPO ETF

-0.48 (-1.10%)

USD 0.14B
PEXL Pacer US Export Leaders ETF

-0.21 (-0.43%)

USD 0.04B

ETFs Containing BOUT

N/A

Market Performance

  Market Performance vs. Industry/Classification (Mid-Cap Growth) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -9.98% 6% D- 20% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -9.98% 6% D- 19% F
Trailing 12 Months  
Capital Gain 0.70% 50% F 49% F
Dividend Return 0.02% 8% B- N/A F
Total Return 0.72% 50% F 38% F
Trailing 5 Years  
Capital Gain 60.99% 61% D- 68% D+
Dividend Return 3.85% 44% F 8% B-
Total Return 64.84% 61% D- 61% D-
Average Annual (5 Year Horizon)  
Capital Gain 8.48% 72% C 68% D+
Dividend Return 9.09% 72% C 63% D
Total Return 0.61% 50% F 14% F
Risk Return Profile  
Volatility (Standard Deviation) 19.42% 61% D- 50% F
Risk Adjusted Return 46.81% 72% C 64% D
Market Capitalization 0.01B 8% B- 7% C-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.